US Patent 9458231 Modulators and methods of use
Patent 9458231 was granted and assigned to Stemcentrx, Inc. on October, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+167 characters)
Article
Patent abstract
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09458231 Modulators and methods of use US Patent 9458231 Modulators and methods of use
Infobox
Patent Number
0945823100
Patent Number
945823100
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
094582310
Date of Patent
October 4, 2016
0Patent Application Number
138199350
Date Filed
September 2, 2011
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
094582310
Date of Patent
October 4, 2016
0Patent Application Number
138199350
Date Filed
September 2, 2011
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09458231 Modulators and methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09458231
Date of patent
October 4, 2016
Patent application number
13819935
Date Filed
September 2, 2011
Patent primary examiner
Find more entities like US Patent 9458231 Modulators and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.